Aperio Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-534,986
| Closed | -$53.1M | – | 2394 |
|
|
2019
Q3 | $53.1M | Buy |
534,986
+4,497
| +0.8% | +$427K | 0.21% | 94 |
|
|
2019
Q2 | $49M | Buy |
530,489
+38,086
| +8% | +$3.62M | 0.2% | 97 |
|
|
2019
Q1 | $46.5M | Buy |
492,403
+85,908
| +21% | +$7.51M | 0.2% | 98 |
|
|
2018
Q4 | $26.1M | Sell |
406,495
-48,545
| -11% | -$3.58M | 0.13% | 173 |
|
|
2018
Q3 | $40.7M | Buy |
455,040
+24,872
| +6% | +$2.2M | 0.18% | 123 |
|
|
2018
Q2 | $34.2M | Buy |
430,168
+8,644
| +2% | +$718K | 0.16% | 140 |
|
|
2018
Q1 | $37.6M | Sell |
421,524
-43,950
| -9% | -$4.22M | 0.19% | 119 |
|
|
2017
Q4 | $48.6M | Sell |
465,474
-21,384
| -4% | -$2.41M | 0.25% | 78 |
|
|
2017
Q3 | $71M | Buy |
486,858
+51,892
| +12% | +$7.07M | 0.4% | 45 |
|
|
2017
Q2 | $56.5M | Buy |
434,966
+35,145
| +9% | +$4.31M | 0.35% | 52 |
|
|
2017
Q1 | $49.8M | Buy |
399,821
+4,203
| +1% | +$503K | 0.34% | 52 |
|
|
2016
Q4 | $45.8M | Buy |
395,618
+21,908
| +6% | +$2.44M | 0.35% | 49 |
|
|
2016
Q3 | $39.1M | Buy |
373,710
+3,988
| +1% | +$432K | 0.28% | 75 |
|
|
2016
Q2 | $36.5M | Buy |
369,722
+25,643
| +7% | +$2.65M | 0.29% | 78 |
|
|
2016
Q1 | $34.4M | Buy |
344,079
+27,660
| +9% | +$2.85M | 0.29% | 69 |
|
|
2015
Q4 | $37.9M | Buy |
316,419
+8,206
| +3% | +$949K | 0.35% | 57 |
|
|
2015
Q3 | $33.3M | Buy |
308,213
+27,561
| +10% | +$3.42M | 0.34% | 58 |
|
|
2015
Q2 | $32.5M | Buy |
280,652
+14,742
| +6% | +$1.69M | 0.34% | 61 |
|
|
2015
Q1 | $30.7M | Buy |
265,910
+23,002
| +9% | +$2.75M | 0.34% | 59 |
|
|
2014
Q4 | $27.2M | Buy |
242,908
+21,693
| +10% | +$2.29M | 0.33% | 58 |
|
|
2014
Q3 | $21M | Buy |
221,215
+20,773
| +10% | +$1.87M | 0.28% | 72 |
|
|
2014
Q2 | $17.2M | Buy |
200,442
+7,796
| +4% | +$593K | 0.25% | 91 |
|
|
2014
Q1 | $13.4M | Buy |
+192,646
| New | +$15.3M | 0.19% | 115 |
|
|
2013
Q4 | – | Sell |
-176,532
| Closed | -$14M | – | 69 |
|
|
2013
Q3 | $13.6M | Buy |
176,532
+25,058
| +17% | +$1.76M | 0.26% | 69 |
|
|
2013
Q2 | $8.86M | Buy |
+151,474
| New | +$9.12M | 0.21% | 98 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Aperio Group's CELG Position: Q4 2019 in Review
Aperio Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 534,986 shares — an estimated $53.1M sold.
Aperio Group first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $71M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Aperio Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Aperio Group sold 534,986 Celgene Corp shares in Q4 2019, an estimated $53.1M.
- Aperio Group first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
- Aperio Group's Celgene Corp position peaked at $71M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.